3 results match your criteria: "West Vicenza General Hospital[Affiliation]"
Comparison of Oral Procainamide and Mexiletine Treatment of Recurrent and Refractory Ventricular Tachyarrhythmias.
J Clin Med
October 2024
Division of Cardiology, University Hospital "S.Maria della Misericordia", P.le S.Maria della Misericordia 15, 33100 Udine, Italy.
Article Synopsis
- The study investigates the effectiveness and tolerability of oral procainamide versus mexiletine for treating recurrent ventricular arrhythmias in patients who didn't respond to standard therapies like amiodarone and beta-blockers.
- Out of 68 patients treated, approximately 56% experienced a significant reduction in arrhythmia burden, with procainamide showing nearly three times higher efficacy compared to mexiletine.
- Side effects were noted in both treatments, but procainamide had a lower discontinuation rate due to severe side effects, suggesting it may be a preferable option for this patient group.
Role of PCSK9 inhibitors in venous thromboembolism: current evidence and unmet clinical needs.
Eur Heart J Cardiovasc Pharmacother
January 2025
Division of Cardiac Rehabilitation, Istituti Clinici Scientifici Maugeri, IRCCS, Gattico-Veruno 28013, Italy.
Article Synopsis
- * Early studies indicate that PCSK9i could help patients who have experienced venous thromboembolism (VTE), with benefits appearing more significant after the first year of treatment.
- * The article reviews current evidence on using PCSK9i alongside standard anticoagulant therapy for VTE risk reduction, highlighting gaps in research and suggesting future strategies to fill these gaps.
Decline of Admission for Acute Coronary Syndromes and Acute Cardiovascular Conditions during COVID-19 Pandemic in Veneto Region.
Viruses
August 2022
Division of Cardiology, West Vicenza General Hospital, Via del Parco 1, 36071 Arzignano, Vicenza, Italy.
Article Synopsis
- The study analyzed hospitalization trends for acute coronary syndrome (ACS) and other acute cardiovascular conditions in the Veneto Region of Italy during the COVID-19 pandemic, comparing data from 2020 to data from 2018 and 2019.
- Researchers found a significant reduction in ACS cases by 27.3% to 32% during the pandemic compared to the historical data, and a similar decrease of 36.5% to 40.6% in acute cardiovascular hospitalizations.
- The study concluded that this decline in hospitalizations could lead to undiagnosed cardiovascular issues, which may increase future morbidity and mortality rates for these conditions.